Cargando…

Missing the Benefit of Metformin in Acute Myeloid Leukemia: A Problem of Contrast?

OBJECTIVE: To evaluate whether metformin's cancer-related benefits reported in patients with solid tumors (ST) are also present in acute myeloid leukemia (AML) patients. METHODS: Baseline demographic and clinical history for all diabetes mellitus patients newly diagnosed with AML or cancer of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ceacareanu, Alice C., Nimako, George K., Wintrob, Zachary A. P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632934/ https://www.ncbi.nlm.nih.gov/pubmed/29026839 http://dx.doi.org/10.4103/jrpp.JRPP_17_37

Ejemplares similares

Application of a Pharmacokinetic Model of Metformin Clearance in a Population with Acute Myeloid Leukemia
por: Ceacareanu, Alice C., et al.
Publicado: (2018)

Statin Type and Cancer Outcomes in Patients with Diabetes Type 2 and Solid Tumors
por: Ceacareanu, Alice C., et al.
Publicado: (2021)

Dataset on growth factor levels and insulin use in patients with diabetes mellitus and incident breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

TH1 and TH2 cytokine data in insulin secretagogues users newly diagnosed with breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

Circulating growth factors data associated with insulin secretagogue use in women with incident breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

Insulin use, hormone receptor status and hematopoietic cytokines׳ circulation in women with diabetes mellitus and breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

Dataset on granulopoiesis- and lymphopoiesis-stimulating cytokine levels in insulin secretagogue users with incident breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

TH1 and TH2 cytokines dataset in insulin users with diabetes mellitus and newly diagnosed breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

Summary of COVID-19 Vaccine-Related Reports in the Vaccine Adverse Event Reporting System
por: Ceacareanu, Alice C., et al.
Publicado: (2021)

Insulin secretagogue use and circulating inflammatory C–C chemokine levels in breast cancer patients
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

Circulating adipokines data associated with insulin secretagogue use in breast cancer patients
por: Wintrob, Zachary A.P., et al.
Publicado: (2016)

Data report on inflammatory C–C chemokines among insulin-using women with diabetes mellitus and breast cancer
por: Wintrob, Zachary A.P., et al.
Publicado: (2017)

15017 Monoclonal antibody use in rheumatoid arthritis: an evaluation of medical expenditure
por: Kelly, Robert A., et al.
Publicado: (2021)

53034 Melatonin use and occurrence of respiratory illnesses
por: Bowen, Hannah M., et al.
Publicado: (2021)

56600 Statin use and medical expenditure in patients with Parkinson’s disease
por: Lo Piccolo, Anthony J., et al.
Publicado: (2021)

67863 Insulin use and depigmentation: a survey of real-world evidence
por: Lukasik, James, et al.
Publicado: (2021)

Metformin suppresses pediatric acute myeloid leukemia cell viability and clonogenicity
por: Gopalakrishnapillai, Anilkumar, et al.
Publicado: (2014)

Analysis of Medical Error Contributing to Missed Acute Myeloid Leukemia Diagnosis
por: Angel, Chelsea, et al.
Publicado: (2019)

Metformin, arterial contrast and acute kidney injury
por: Amos, Lal, et al.
Publicado: (2019)

Impact of metformin on tyrosine kinase inhibitor response in chronic myeloid leukemia
por: Pokorny, Rebecca, et al.
Publicado: (2022)

Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells
por: Renner, Kathrin, et al.
Publicado: (2018)

Metformin exerts a synergistic effect with venetoclax by downregulating Mcl-1 protein in acute myeloid leukemia
por: Zhou, Fang-jiao, et al.
Publicado: (2021)

An undiagnosed case of acute myeloid leukemia
por: Babu, S. P. K. Kennedy, et al.
Publicado: (2014)

Acute Myeloid Leukemia
Publicado: (2019)

Acute myeloid leukemia
por: Haferlach, Torsten
Publicado: (2019)

Acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2018)

Myeloperoxidase Expression in Acute Myeloid Leukemia Helps Identifying Patients to Benefit from Transplant
por: Kim, Yundeok, et al.
Publicado: (2012)

Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia
por: Wei, Hui, et al.
Publicado: (2020)

Benefit of the Reduced Dose Combination of Azacitidine and Venetoclax in an Elderly Patient With Acute Myeloid Leukemia
por: Fujino, Keita, et al.
Publicado: (2023)

Patient‐Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia
por: El‐Jawahri, Areej, et al.
Publicado: (2018)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

High Metabolic Dependence on Oxidative Phosphorylation Drives Sensitivity to Metformin Treatment in MLL/AF9 Acute Myeloid Leukemia
por: Liu, Longlong, et al.
Publicado: (2022)

Novel Translocation in Acute Myeloid Leukemia: Case Report and Review of Risk-Stratification and Induction Chemotherapy in Patients With Acute Myeloid Leukemia
por: Jeha, George M., et al.
Publicado: (2020)

S100 Proteins in Acute Myeloid Leukemia()()
por: Brenner, Annette K., et al.
Publicado: (2018)

Acute Myeloid Leukemia: Is That All There Is?
por: Saif, Aneeqa, et al.
Publicado: (2018)

Classification of acute myeloid leukemia
por: Hwang, Sang Mee
Publicado: (2020)

Acute Myeloid Leukemia: Is It T Time?
por: Khoud, Meriem Ben, et al.
Publicado: (2021)

Cerebral aspergillosis and acute myeloid leukemia
por: Matis, Georgios K, et al.
Publicado: (2013)

A Screening of Antineoplastic Drugs for Acute Myeloid Leukemia Reveals Contrasting Immunogenic Effects of Etoposide and Fludarabine
por: Ocadlikova, Darina, et al.
Publicado: (2020)

Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells
por: Na, Yoo Jin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h165ivs7pkbn8755i6rs372ef5